Yukie Kashima
Karolinska Institutet(SE)The University of Tokyo(JP)
Publications by Year
Research Areas
Cancer Genomics and Diagnostics, Single-cell and spatial transcriptomics, Lung Cancer Treatments and Mutations, SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies
Most-Cited Works
- → Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant(2022)740 cited
- → Single-cell sequencing techniques from individual to multiomics analyses(2020)262 cited
- → Single-Cell Analyses Reveal Diverse Mechanisms of Resistance to EGFR Tyrosine Kinase Inhibitors in Lung Cancer(2021)102 cited
- → CD70 is a therapeutic target upregulated in EMT-associated EGFR tyrosine kinase inhibitor resistance(2023)97 cited
- → Combination treatment with a PI3K/Akt/mTOR pathway inhibitor overcomes resistance to anti-HER2 therapy in PIK3CA-mutant HER2-positive breast cancer cells(2020)85 cited
- → Comparative pathogenicity of SARS-CoV-2 Omicron subvariants including BA.1, BA.2, and BA.5(2023)60 cited
- → Long-read sequencing for non-small-cell lung cancer genomes(2020)50 cited
- → Single-cell and spatial analyses of cancer cells: toward elucidating the molecular mechanisms of clonal evolution and drug resistance acquisition(2021)43 cited
- → Comparative Analysis of Patient-Matched PDOs Revealed a Reduction in OLFM4-Associated Clusters in Metastatic Lesions in Colorectal Cancer(2021)38 cited
- → Three-step transcriptional priming that drives the commitment of multipotent progenitors toward B cells(2018)35 cited